Access

Letters to Nature

Nature 413, 425-428 (27 September 2001) | doi:10.1038/35096571; Received 3 July 2001; Accepted 9 August 2001

Open Innovation Challenges

naturejobs

Auxin transport inhibitors block PIN1 cycling and vesicle trafficking

Niko Geldner1,2, Jir caroní Friml2,3,4,5, York-Dieter Stierhof1, Gerd Jürgens1 & Klaus Palme3

  1. Zentrum für Molekularbiologie der Pflanzen, Universität Tübingen, Auf der Morgenstelle 3, D-72076 Tübingen, Germany
  2. Max-Delbrück-Laboratorium in der Max-Planck-Gesellschaft, D-50829 Köln, Germany
  3. Department of Biochemistry, Faculty of Science, Masaryk University, Kotlárská 2, 61137 Brno, Czech Republic
  4. These authors contributed equally to this work
  5. Present address: Zentrum für Molekularbiologie der Pflanzen, Universität Tübingen, Auf der Morgenstelle 3, D-72076 Tübingen, Germany.

Correspondence to: Gerd Jürgens1 Correspondence and requests for materials should be addressed to G.J. (e-mail: Email: gerd.juergens@zmbp.uni-tuebingen.de).

Top

Polar transport of the phytohormone auxin mediates various processes in plant growth and development, such as apical dominance, tropisms, vascular patterning and axis formation1, 2. This view is based largely on the effects of polar auxin transport inhibitors. These compounds disrupt auxin efflux from the cell but their mode of action is unknown3. It is thought that polar auxin flux is caused by the asymmetric distribution of efflux carriers acting at the plasma membrane4. The polar localization of efflux carrier candidate PIN1 supports this model4. Here we show that the seemingly static localization of PIN1 results from rapid actin-dependent cycling between the plasma membrane and endosomal compartments. Auxin transport inhibitors block PIN1 cycling and inhibit trafficking of membrane proteins that are unrelated to auxin transport. Our data suggest that PIN1 cycling is of central importance for auxin transport and that auxin transport inhibitors affect efflux by generally interfering with membrane-trafficking processes. In support of our conclusion, the vesicle-trafficking inhibitor brefeldin A mimics physiological effects of auxin transport inhibitors.